{
  "timestamp": "2025-04-19 14:56:50",
  "phase": "Evolution",
  "round": 4,
  "elo_score": null,
  "content": "Patient stratification by DNA damage and innate immune biomarkers will identify subgroups benefiting from cGAS-STING pathway modulation as a cancer prevention or early intervention strategy [Shiloh 2001]; [Hartlova 2015]; [Ablasser 2019].  \n*New support:* [Li & Chen 2018, Nat Rev Immunol].\n\n---"
}